Triple-negative Breast Cancer
📧 Sign up to get email alerts when something new happens for Triple-negative Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer [Phase 1, Phase 2]
A Phase 1/2 study of TC-510 from TCR2 Therapeutics in mesothelin-expressing cancers is active but not recruiting, spanning multiple indicati…
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: Implantable Microdevice for In Vivo Drug Sensitivity Testing in Patients With Early Stage, HER2-Positive or Triple Negative Breast Cancer [NA]
Completed clinical trial evaluating an implantable microdevice to test in vivo drug sensitivity in patients with early-stage HER2-positive o…
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: A Study of ADRX-0706 in Select Advanced Solid Tumors [Phase 1]
Phase 1 study of ADRX-0706 in select advanced solid tumors is active/not recruiting, evaluating the investigational agent in triple-negative…
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies [Phase 1]
Phase 1 dose-escalation and expansion study of intratumoral mRNA-2752 in advanced malignancies has completed, with expansion cohorts in seve…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors [EARLY_Phase 1]
Early-phase study update on intratumoral microdose administration of PBA-0405 in solid tumors; the trial status is completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours [Phase 1, Phase 2]
Cancer Research UK reported an ongoing Phase 1/2a trial of HMBD-001 in HER3-positive solid tumors; the study is currently Active Not Recruit…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors [Phase 1]
Phase 1, first-in-human dose-finding and expansion study of XmAb808 in combination with pembrolizumab in advanced solid tumors; the trial ha…
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: MGC018 With or Without MGA012 in Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports results from the combination of MGC018 with or without MGA012 (pembrolizumab) in advanced solid tumors. T…
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Image-based AI Predictive Biomarkers for Precision Neoadjuvant Triple-negative Breast Cancer Treatment
The clinical trial NCT05435352 evaluating image-based AI predictive biomarkers for precision neoadjuvant treatment in triple-negative breast…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Testing the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast Cancer [Phase 1, Phase 2]
Clinical trial update reports on the combination of copanlisib and eribulin in metastatic triple-negative breast cancer in Phase 1/2, with r…
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: Safety of TT-00420 (Tinengotinib) Monotherapy in Patients With Advanced Solid Tumors and Triple Negative Breast Cancer [Phase 1]
Phase 1 safety data for Tinengotinib (TT-00420) as monotherapy in patients with advanced solid tumors and triple-negative breast cancer has …
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: NM32-2668 in Adult Patients With Selected Advanced Solid Tumors [Phase 1]
A Phase 1 trial of NM32-2668 in adults with selected advanced solid tumors has been terminated. The study enrolled multiple tumor types incl…
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Deferoxamine Plus Chemotherapy for Metastatic Triple Negative Breast Cancer [Phase 2]
A Phase 2 trial evaluating deferoxamine in combination with chemotherapy for metastatic triple-negative breast cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-07-21Clinical Trial Update: Chidamide Combined With Zimberelimab in the Treatment of Metastatic Triple-negative Breast Cancer Patients [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating the combination of chidamide and zimberelimab for metastatic tri…
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Inosine Reverse Chemo Resistance in Triple Negative Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating inosine to reverse chemotherapy resistance in triple-negative breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours [Phase 1, Phase 2]
NuCana plc announced termination of a Phase 1/2 trial evaluating NUC-3373 in combination with other agents for patients with advanced solid …
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease [Phase 3]
Phase 3 trial comparing Niraparib to placebo in HER2-negative breast cancer with BRCA mutation or triple-negative disease, with results repo…
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update announcing the termination of a Phase 1/2 study evaluating Fruquintinib in combination with Tislelizumab in adults w…
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors [Phase 1]
A Phase 1 trial of INCB106385, alone or with immunotherapy, in advanced solid tumors has completed. The study includes multiple indications …
-
CLINICAL_TRIALS trial_result · 2025-07-04Clinical Trial Update: A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors [Phase 1]
This Phase 1 trial assesses Autogene Cevumeran (RO7198457) as a single agent and in combination with atezolizumab across multiple locally ad…
-
CLINICAL_TRIALS trial_result · 2025-07-04Clinical Trial Update: A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer [Phase 2]
Phase 2 clinical trial update examining pembrolizumab with carboplatin and gemcitabine in metastatic triple-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy [Phase 2]
This Phase 2 clinical trial update evaluates pembrolizumab in patients with stage IV inflammatory breast cancer or triple-negative breast ca…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: A Biomarker Screening Protocol for Participants With Solid Tumors
A clinical trial update describes a biomarker screening protocol for participants with solid tumors, and the study has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: Rintatolimod, Celecoxib and Interferon Alpha 2b With Pembrolizumab For the Treatment of Patients With Metastatic or Unresectable Triple Negative Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating rintatolimod in combination with celecoxib, interferon alfa-2b, and pembrolizumab for metastatic or unresectabl…
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer [NA]
A completed Emory University study evaluating a mobile health intervention to improve adherence to oral chemotherapy in women with breast ca…